NCT00855179 - Assess the Efficacy and Tolerability of Antistax Film-coated Tablets in Patients With Chronic Venous Insufficiency | Biotech Hunter

Enrollment

250

Participants

Timeline

Start Date

March 31, 2009

Primary Completion Date

November 30, 2009

Conditions

Venous Insufficiency

Interventions

DRUG

Red vine leaf extract (AS 195)

Antistax film-coated tablet 360 mg

DRUG

Placebo

Placebo tablets identical to those containing Anstistax 360 mg

Trial Locations (20)

1138.11.49004 Boehringer Ingelheim Investigational Site, Berlin

1138.11.49016 Boehringer Ingelheim Investigational Site, Berlin

1138.11.49019 Boehringer Ingelheim Investigational Site, Bochum

1138.11.49014 Boehringer Ingelheim Investigational Site, Bonn

1138.11.49023 Boehringer Ingelheim Investigational Site, Breisach

1138.11.49003 Boehringer Ingelheim Investigational Site, Coburg

1138.11.49013 Boehringer Ingelheim Investigational Site, Cologne

1138.11.49024 Boehringer Ingelheim Investigational Site, Dülmen

1138.11.49007 Boehringer Ingelheim Investigational Site, Freiburg im Breisgau

1138.11.49020 Boehringer Ingelheim Investigational Site, Freiburg im Breisgau

1138.11.49009 Boehringer Ingelheim Investigational Site, Greifswald

1138.11.49010 Boehringer Ingelheim Investigational Site, Lübeck

1138.11.49011 Boehringer Ingelheim Investigational Site, Mainz

1138.11.49012 Boehringer Ingelheim Investigational Site, Minden

1138.11.49005 Boehringer Ingelheim Investigational Site, München

1138.11.49022 Boehringer Ingelheim Investigational Site, Oberhausen

1138.11.49002 Boehringer Ingelheim Investigational Site, Oberkirch

1138.11.49001 Boehringer Ingelheim Investigational Site, Rottach-Egern

1138.11.49006 Boehringer Ingelheim Investigational Site, Rottweil

1138.11.49018 Boehringer Ingelheim Investigational Site, Tübingen